Vox Markets Interview with Avacta CEO Alastair Smith

0 Bekeken· 09/19/23
The Vox Markets Podcast
0
In

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

Laat meer zien

 0 Comments sort   Sorteer op


Volgende